Description
The abstract reveals an unexpected contradiction where PRKN activation, normally considered neuroprotective through damaged mitochondria removal, actually depletes healthy mitochondria from synapses in tauopathy. This challenges the established view of mitophagy as purely beneficial and suggests context-dependent mechanisms that remain unexplained.
Gap type: contradiction Source paper: Broad activation of the PRKN pathway triggers synaptic failure by disrupting synaptic mitochondrial supply in early tauopathy. (None, None, PMID:35188059)
Resolution criteria
Resolution requires: (1) Longitudinal imaging (e.g., MitoTimer, PINK1-GFP reporters) in primary tauopathy neurons demonstrating that PRKN activation preferentially marks healthy versus damaged mitochondria for degradation, with ≥40% reduction in total mitochondrial mass versus ≤20% reduction in tau-expressing control cells; (2) Identification of the tau-specific signal that aberrantly recruits PRKN to healthy mitochondria (e.g., aberrant tau-mitochondria interactions measurable by proximity ligation or co-IP in ≥3 tauopathy models); (3) Genetic or pharmacological inhibition of PRKN restoring synaptic mitochondrial density ≥50% in tauopathy models while not worsening pathological tau phenotypes, demonstrating therapeutic viability.